APA 6th Edition

Kehler, T. (2011). The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients. Reumatizam, 58 (2), 189-189. Retrieved from https://hrcak.srce.hr/124473

---

MLA 8th Edition

Kehler, Tatjana. "The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients." Reumatizam, vol. 58, no. 2, 2011, pp. 189-189. https://hrcak.srce.hr/124473. Accessed 17 Nov. 2024.

---

Chicago 17th Edition

Kehler, Tatjana. "The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients." Reumatizam 58, no. 2 (2011): 189-189. https://hrcak.srce.hr/124473

---

Harvard

Kehler, T. (2011). 'The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients', Reumatizam, 58(2), pp. 189-189. Available at: https://hrcak.srce.hr/124473 (Accessed 17 November 2024)

---

Vancouver

Kehler T. The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients. Reumatizam [Internet]. 2011 [cited 2024 November 17];58(2):189-189. Available from: https://hrcak.srce.hr/124473

---

IEEE

T. Kehler, "The safety of rituximab (Mabthera®) treatment in rheumatoid arthritis patients", Reumatizam, vol.58, no. 2, pp. 189-189, 2011. [Online]. Available: https://hrcak.srce.hr/124473. [Accessed: 17 November 2024]